Literature DB >> 16911959

R104H may suppress transthyretin amyloidogenesis by thermodynamic stabilization, but not by the kinetic mechanism characterizing T119 interallelic trans-suppression.

Yoshiki Sekijima1, Maria T Dendle, R Luke Wiseman, Joleen T White, Wim D'Haeze, Jeffery W Kelly.   

Abstract

The tetrameric protein transthyretin (TTR) forms amyloid fibrils upon dissociation and subsequent monomer misfolding, enabling misassembly. Remarkably, the aggregation of one of over 100 destabilized TTR variants leads to familial amyloid disease. It is known that trans-suppression mediated by the incorporation of T119M subunits into tetramers otherwise composed of the most common familial variant V30M, ameliorates disease by substantially slowing the rate of tetramer dissociation, a mechanism referred to as kinetic stabilization of the native state. R104H TTR has been reported to be non-pathogenic, and recently, this variant has been invoked as a trans-suppressor of amyloid fibril formation. Here, we demonstrate that the trans-suppression mechanism of R104H does not involve kinetic stabilization of the tetrameric structure, instead its modest trans-suppression most likely results from the thermodynamic stabilization of the tetrameric TTR structure. Thermodynamic stabilization increases the fraction of tetramer at the expense of the misfolding competent monomer decreasing the ability of TTR to aggregate into amyloid fibrils. As a consequence of this stabilization mechanism, R104H may be capable of protecting patients with modestly destabilizing mutations against amyloidosis by slightly lowering the overall population of monomeric protein that can misfold and form amyloid.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16911959     DOI: 10.1080/13506120600722449

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  7 in total

1.  Enthalpy-Driven Stabilization of Transthyretin by AG10 Mimics a Naturally Occurring Genetic Variant That Protects from Transthyretin Amyloidosis.

Authors:  Mark Miller; Arindom Pal; Wabel Albusairi; Hyun Joo; Beverly Pappas; Md Tariqul Haque Tuhin; Dengpan Liang; Raghavendra Jampala; Fang Liu; Jared Khan; Marjon Faaij; Miki Park; William Chan; Isabella Graef; Robert Zamboni; Neil Kumar; Jonathan Fox; Uma Sinha; Mamoun Alhamadsheh
Journal:  J Med Chem       Date:  2018-08-22       Impact factor: 7.446

Review 2.  'Let the phage do the work': using the phage P22 coat protein structures as a framework to understand its folding and assembly mutants.

Authors:  Carolyn M Teschke; Kristin N Parent
Journal:  Virology       Date:  2010-03-16       Impact factor: 3.616

3.  Three Newly Recognized Likely Pathogenic Gene Variants Associated with Hereditary Transthyretin Amyloidosis.

Authors:  Jignesh K Patel; Andrew M Rosen; Adam Chamberlin; Benjamin Feldmann; Christian Antolik; Heather Zimmermann; Tami Johnston; Arvind Narayana
Journal:  Neurol Ther       Date:  2022-08-06

4.  [What gnaws at the heart and gets on the nerves].

Authors:  Arnt V Kristen
Journal:  Internist (Berl)       Date:  2018-11       Impact factor: 0.743

5.  Cavity filling mutations at the thyroxine-binding site dramatically increase transthyretin stability and prevent its aggregation.

Authors:  Ricardo Sant'Anna; Maria Rosário Almeida; Nathalia Varejāo; Pablo Gallego; Sebastian Esperante; Priscila Ferreira; Alda Pereira-Henriques; Fernando L Palhano; Mamede de Carvalho; Debora Foguel; David Reverter; Maria João Saraiva; Salvador Ventura
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

Review 6.  Molecular Mechanisms of Cardiac Amyloidosis.

Authors:  Yukihiro Saito; Kazufumi Nakamura; Hiroshi Ito
Journal:  Int J Mol Sci       Date:  2021-12-21       Impact factor: 5.923

Review 7.  The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism.

Authors:  Chiara Sanguinetti; Marianna Minniti; Vanessa Susini; Laura Caponi; Giorgia Panichella; Vincenzo Castiglione; Alberto Aimo; Michele Emdin; Giuseppe Vergaro; Maria Franzini
Journal:  Biomedicines       Date:  2022-08-06
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.